Paediatric Rheumatology [ACR22] Paediatric Rheumatology 29 Nov 20226 Dec 2022 Author: Thomas Renson Ramanan et al (2210) presented phase 3 efficacy and safety data of baricitinib in 220 (non-systemic) juvenile idiopathic arthritis (JIA) patients. 63.5% of the patients achieved a…
Metabolic and Crystal Arthropathies [ACR22] Metabolic and Crystal Arthropathies 29 Nov 20226 Dec 2022 Author: Diego Benavent Botson et al (0001) assessed the efficacy and safety of pegloticase (PEGylated uricase) with methotrexate (MTX) vs placebo (PBO) as co-therapy, in the MIRROR RCT trial. Efficacy…
Spondyloarthritis II - therapeutic [ACR22] Spondyloarthritis II – Therapeutic 29 Nov 20226 Dec 2022 Author: Jean-Guillaume Letarouilly Baraliakos et al. (0420) studied the differences in the velocity and magnitude of NSAID response velocity in patients with established bDMARD naïve axSpA versus patients with other,…
Spondyloarthritis [ACR22] Spondyloarthritis I – Non-therapeutic 29 Nov 20226 Dec 2022 Author: Jean-Guillaume Letarouilly Sieiro Santos et al. (0373) developed a prognostic outcome score for patients with uveitis associated with SpA (SpA-U) and determine factors associated with adverse outcomes in uveitis…